Jurgen Damen only had one year at Erasmus with an academic cover. He was currently a BioNTech financier, and before that he was a financier for 26 years for Middle East investment in Europe with Dion. Valantic did the private placements for BioNTech for COVID mRNA and cancer mRNA… pic.twitter.com/3jzB1ivkfq

— George Webb - Investigative Journalist (@RealGeorgeWebb1) September 29, 2023